Drug Profile

Lidocaine/nifedipine cloth - Steel Therapeutics

Alternative Names: Fizurex(Tm) - Steel Therapeutics; Nifedipine/lidocaine cloth - Steel Therapeutics

Latest Information Update: 26 Sep 2025

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Steel Therapeutics
Class Acetamides; Acetanilides; Amines; Dihydropyridines; Local anaesthetics; Non-opioid analgesics; Small molecules
Mechanism of Action Calcium channel antagonists; Cell membrane permeability inhibitors; Opioid receptor agonists; Sodium channel antagonists

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity No

21 Aug 2025 Preclinical trials in Fissure in ano in USA (Topical)
21 Aug 2025 Steel Therapeutics plans to file an Investigational New Drug (IND) application for Lidocaine/nifedipine cloth for Fissure-in-ano in USA(Topical) in early 2026

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com